Dr Andrew Howe

Honorary Associate
Anatomy & Histology, School of Medical Sciences

Telephone +61 2 9351 2674
Fax +61 2 9351 2813

Map

Selected grants

2014

  • The role of foetal hypoxia and hyperglycaemia in the formation of cleft lip maxillary hypoplasia; Howe A, Ritchie H, Webster W; Australian Dental Research Foundation/Research Support.

2009

  • The role of foetal hypoxia in cleft lip and maxillary hypoplasia; Howe A, Oakes D, Webster W, Ritchie H; Australian Dental Research Foundation/Research Support.
  • Prenatal facial development and the role of oxygen; Oakes D, Ritchie H, Webster W, Howe A; Dental Board of NSW/Research Support.

2003

  • Hypoxia and embryonic development; Howe A; Australian Dental Research Foundation/Research Grants.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Webster, W., Howe, A., Abela, D., Oakes, D. (2006). The relationship between cleft lip maxillary hypoplasia, hypoxia and phenytoin. Current Pharmaceutical Design, 12(12), 1431-1448. [More Information]
  • Abela, D., Howe, A., Oakes, D., Webster, W. (2005). Maternal antioxidant supplementation does not reduce the incidence of phenytoin-induced cleft lip and related malformations in rats. Birth Defects Research. Part B: Developmental and Reproductive Toxicology, 74(2), 201-206. [More Information]
  • Howe, A., Hawkins, J., Webster, W. (2004). The Growth Of The Nasal Septum In The 6-9 Week Period Of Foetal Development--Warfarin Embryopathy Offers A New Insight Into Prenatal Facial Development. Australian Dental Journal, 49(4), 171-176.

2006

  • Webster, W., Howe, A., Abela, D., Oakes, D. (2006). The relationship between cleft lip maxillary hypoplasia, hypoxia and phenytoin. Current Pharmaceutical Design, 12(12), 1431-1448. [More Information]

2005

  • Abela, D., Howe, A., Oakes, D., Webster, W. (2005). Maternal antioxidant supplementation does not reduce the incidence of phenytoin-induced cleft lip and related malformations in rats. Birth Defects Research. Part B: Developmental and Reproductive Toxicology, 74(2), 201-206. [More Information]

2004

  • Howe, A., Hawkins, J., Webster, W. (2004). The Growth Of The Nasal Septum In The 6-9 Week Period Of Foetal Development--Warfarin Embryopathy Offers A New Insight Into Prenatal Facial Development. Australian Dental Journal, 49(4), 171-176.

To update your profile click here. For support on your academic profile contact .